Fermenta Biotec.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE225B01021
  • NSEID: FERMENTA
  • BSEID: 506414
INR
475.75
10.4 (2.23%)
BSENSE

Sep 18, 03:30 PM

BSE+NSE Vol: 29.63 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Syncom Formul.
Kopran
NGL Fine Chem
Lincoln Pharma.
Jagsonpal Pharma
Sigachi Indust.
Themis Medicare
Bajaj Healthcare
Fermenta Biotec.
Amrutanjan Healt
Accent Microcell

Why is Fermenta Biotech Ltd ?

1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 8.88%
  • Poor long term growth as Net Sales has grown by an annual rate of 5.42% and Operating profit at 1.72% over the last 5 years
2
With a fall in Net Sales of -10.6%, the company declared Very Negative results in Jun 26
  • The company has declared negative results for the last 3 consecutive quarters
  • The company has declared negative results in Dec 25 after 5 consecutive negative quarters
  • NET SALES(Q) At Rs 121.82 cr has Fallen at -10.60%
  • PBDIT(Q) Lowest at Rs 18.06 cr.
  • OPERATING PROFIT TO NET SALES(Q) Lowest at 14.83%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Fermenta Biotec. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Fermenta Biotec.
38.91%
0.80
48.85%
Sensex
-10.5%
-0.78
13.50%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
5.42%
EBIT Growth (5y)
1.72%
EBIT to Interest (avg)
2.92
Debt to EBITDA (avg)
6.43
Net Debt to Equity (avg)
0.18
Sales to Capital Employed (avg)
0.80
Tax Ratio
29.44%
Dividend Payout Ratio
14.98%
Pledged Shares
0
Institutional Holding
0.39%
ROCE (avg)
8.03%
ROE (avg)
8.36%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
26
Industry P/E
37
Price to Book Value
3.46
EV to EBIT
21.56
EV to EBITDA
16.49
EV to Capital Employed
3.09
EV to Sales
2.89
PEG Ratio
NA
Dividend Yield
0.78%
ROCE (Latest)
16.34%
ROE (Latest)
16.45%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
DEBT-EQUITY RATIO(HY)

Lowest at 0.28 times

-24What is not working for the Company
NET SALES(Q)

At Rs 121.82 cr has Fallen at -10.60%

PBDIT(Q)

Lowest at Rs 18.06 cr.

OPERATING PROFIT TO NET SALES(Q)

Lowest at 14.83%

PBT LESS OI(Q)

Lowest at Rs 10.32 cr.

PAT(Q)

Lowest at Rs 9.74 cr.

EPS(Q)

Lowest at Rs 3.40

Loading Valuation Snapshot...

Here's what is working for Fermenta Biotec.

Debt-Equity Ratio - Half Yearly
Lowest at 0.28 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Fermenta Biotec.

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 10.32 cr has Fallen at -46.58%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 9.74 cr has Fallen at -55.4%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 121.82 cr has Fallen at -10.60%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 18.06 cr. and Fallen
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at 14.83% and Fallen
each quarter in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 10.32 cr. and Fallen
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Lowest at Rs 9.74 cr. and Fallen
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs 3.40
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)